Dosage and administration
Dogs and Cats : 0.1 to 0.5 mL injected Intramuscularly or Subcutaneously. Cattle , Horses , Sheep and Swine : 1 mL per 100 lbs of body weight injected Intramuscularly or Subcutaneously.
Dogs and Cats : 0.1 to 0.5 mL injected Intramuscularly or Subcutaneously. Cattle , Horses , Sheep and Swine : 1 mL per 100 lbs of body weight injected Intramuscularly or Subcutaneously.
Store at controlled room temperature between 15° and 30°C (59° - 86°F) . Protect from light . TAKE TIME OBSERVE LABEL DIRECTIONS
1 mg/mL
STERILE MULTIPLE DOSE VIAL
FOR ANIMAL USE ONLY
KEEP OUT OF REACH OF CHILDREN
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
INDICATIONS
For emergency use only in treating anaphylactoid shock in sheep, swine, cattle, horses, dogs and cats.
Dogs and Cats: 0.1 to 0.5 mL injected Intramuscularly or Subcutaneously.
Cattle, Horses, Sheep and Swine: 1 mL per 100 lbs of body weight injected Intramuscularly or Subcutaneously.
Do not use this product if it's color is pinkish or darker than slightly yellow or if it contains a precipitate.
Each mL of sterile aqueous solution contains:
Epinephrine ....................... 1 mg
Sodium Chloride ................ 0.1%
Benzyl Alcohol .................. 1.5%
Disodium Edetate, Sodium Metabisulfite, Hydrochloric Acid, and Water for Injection.
Store at controlled room temperature between 15° and 30°C (59° - 86°F).
Protect from light.
TAKE TIME OBSERVE LABEL DIRECTIONS
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 310132 | EPINEPHrine 1 MG/ML (1:1000) Injectable Solution | PSN | 9 |
| 310132 | epinephrine 1 MG/ML Injectable Solution | SCD | 9 |
| 310132 | epinephrine (as epinephrine hydrochloride) 1 MG/ML Injectable Solution | SY | 9 |
| 310132 | epinephrine 1:1000 Injectable Solution | SY | 9 |
| 310132 | epinephrine 500 MCG per 0.5 ML Injectable Solution | SY | 9 |
| Class | Version | Type | Effective |
|---|---|---|---|
| EPINEPHRINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0b4ec9ca-d305-43fc-88dd-7a510313efe0 | Product name | 1 | 20260105 |
| bb209f42-a85f-4fee-9d3d-c9dded168625 | Product name | 1 | 20251208 |
| 49628fc7-2031-4c28-bd31-0ef3aa8f44a3 | Product name | 3 | 20251118 |
| cbf85893-59ef-423f-87d4-a573c000a8b9 | Product name | 8 | 20250731 |
| b5b1095b-40cd-8a9e-b111-502545045b07 | Product name | 4 | 20250325 |
| e190029e-423b-473c-8e04-2ada59b5b711 | Product name | 1 | 20250314 |
| e0031c74-3853-42bc-8e10-86dbbe83992e | Product name | 2 | 20231116 |
| f7046b89-2016-499a-adc6-78479172abc6 | Product name | 1 | 20230425 |
| 2686d634-e712-4007-8dbf-3d37c6c4d71f | Product name | 1 | 20181121 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| bd49bb86-2d32-4a7a-a594-eeda2e29af42 | Product name | 1 | 20180118 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 3becbe78-12d9-4ad2-9b4c-1e36f8d1303a | Product name | 1 | 20170815 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58005-004-02 | EPINEPHRINE | 50 mL in 1 VIAL | INJECTION | 50 | 9 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| EPINEPHRINE | ACTIVE INGREDIENT | YKH834O4BH | 4 | |
| EPINEPHRINE | ACTIVE MOIETY | YKH834O4BH | 4 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 58005-004 | 58005-004-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| EPINEPHRINE | YKH834O4BH | ACTIB |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | EMULSION / OPHTHALMIC | 0.3 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, COATED / ORAL | 0.21 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / TOPICAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | GEL / TRANSDERMAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVENOUS | 10 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO, SUSPENSION / TOPICAL | 1 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / RECTAL | 97 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SPRAY / RESPIRATORY (INHALATION) | 0.05 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / INTRAVENOUS | 0.03 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, EFFERVESCENT / ORAL | 32 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, ORALLY DISINTEGRATING / ORAL | 3 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / AURICULAR (OTIC) | 0.01 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / AURICULAR (OTIC) | 0.05 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / INTRAVENOUS | 0.05 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAMUSCULAR | 10 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAVENOUS | 7 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRACARDIAC | 2 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | GEL / OPHTHALMIC | 396 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / SOFT TISSUE | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | ENEMA / RECTAL | 60 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, EXTENDED RELEASE / ORAL | 10 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRABURSAL | 0.01 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / RECTAL | 2 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / SUBCUTANEOUS | 2 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / ORAL | 432 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / ORAL | 30 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / ORAL | 0.5 mg/1ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / OPHTHALMIC | 0.06 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / AURICULAR (OTIC) | 0.1 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 6 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / RESPIRATORY (INHALATION) | 0.01 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / OPHTHALMIC | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SOFT TISSUE | 0.05 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAMUSCULAR | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / AURICULAR (OTIC) | 0.01 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CONCENTRATE / ORAL | 20 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, FILM COATED / ORAL | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM, AUGMENTED / TOPICAL | 2 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / OPHTHALMIC | 0.05 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVASCULAR | 0.48 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CAPSULE / ORAL | 5 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SPRAY, METERED / NASAL | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | EMULSION / TOPICAL | 0.11 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | GEL / VAGINAL | 5 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / OPHTHALMIC | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | POWDER, FOR SUSPENSION / ORAL | 285 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / TOPICAL | 126 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET / ORAL | 100 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, DELAYED RELEASE / ORAL | 100 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION/ DROPS / OPHTHALMIC | 0.13 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | ELIXIR / ORAL | 1.3 mg/5ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYRUP / ORAL | 40 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / NASAL | 2 mg/1ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRA-ARTICULAR | 0.05 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / NASAL | 100 mg/100ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / INTRAMUSCULAR | 1 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EPINEPHRINE | EPINEPHRINE | REMEDYREPACK INC. | 55befbe4-c819-4367-bbe7-de5841786aac | 2026-09-03 | Warnings, Adverse reactions | EPINEPHRINE EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | REMEDYREPACK INC. | 5ba14408-c8fb-4734-aad9-ee19696acac2 | 2026-08-28 | Warnings, Adverse reactions | EPINEPHRINE EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 5725a519-3ad6-7e5e-e063-6394a90a111f | 2026-08-10 | Warnings, Adverse reactions | EPINEPHRINE EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 5726eeca-db88-ba8e-e063-6294a90a927d | 2026-08-03 | Warnings, Adverse reactions | EPINEPHRINE EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | Fresenius Kabi USA, LLC | a6afb9e8-1db9-480c-8d31-58c5c870ca49 | 2026-07-29 | Warnings, Adverse reactions | EPINEPHRINE EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | Fresenius Kabi USA, LLC | 4f83895f-638c-4515-af03-7c41ae60a42e | 2026-07-15 | Warnings, Adverse reactions | EPINEPHRINE EPINEPHRINE |
| Epinephrine | EPINEPHRINE | A-S Medication Solutions | 6e811e28-0199-4df7-a916-5940c632401d | 2026-07-13 | Warnings, Adverse reactions | Epinephrine EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | CIVICA, INC. | 4a79ad00-405b-4454-a692-7f1daac4adec | 2026-07-10 | Warnings, Adverse reactions | EPINEPHRINE EPINEPHRINE |
| Epinephrine | EPINEPHRINE | A-S Medication Solutions | 386519ba-7a44-4edd-9eb1-748419b7a71b | 2026-07-06 | Warnings, Adverse reactions | Epinephrine EPINEPHRINE |
| Adrenalin | EPINEPHRINE | Par Health USA, LLC | 3b7a4364-668d-4eb2-a20c-04adc35aabe4 | 2026-07-01 | Warnings, Adverse reactions | EPINEPHRINE |
| Epinephrine | EPINEPHRINE | REMEDYREPACK INC. | 0172280c-f7d6-4613-9dbd-f94d3ae5825a | 2026-06-08 | Warnings, Adverse reactions | Epinephrine EPINEPHRINE |
| Epinephrine | EPINEPHRINE | Hikma Pharmaceuticals USA Inc. | 1e8ebac1-5b32-47f9-a930-86a98a24dccc | 2026-05-05 | Warnings, Adverse reactions | Epinephrine EPINEPHRINE |
| Epinephrine | EPINEPHRINE | Sportpharm LLC | 3a8f5ca2-6c1d-4011-9266-ba93c7a3abb9 | 2026-04-24 | Warnings, Adverse reactions | Epinephrine EPINEPHRINE |
| neffy | EPINEPHRINE | Sportpharm LLC | 2052f9db-7d76-443b-b702-b6b499f9a4b8 | 2026-04-24 | Warnings, Adverse reactions | EPINEPHRINE |
| neffy | EPINEPHRINE | ARS Pharmaceuticals Operations, Inc. | a1758142-a905-401d-8961-05829f51023a | 2026-04-09 | Warnings, Adverse reactions | EPINEPHRINE |
| Adrenalin | EPINEPHRINE | Par Health USA, LLC | a5ce0c01-dd47-4997-ab09-490de65d3835 | 2026-04-08 | Warnings, Adverse reactions | EPINEPHRINE |
| Adrenalin | EPINEPHRINE | Par Health USA, LLC | b27e06aa-5b40-44bc-8de7-80b027580a3b | 2026-04-08 | Warnings, Adverse reactions | EPINEPHRINE |
| epinephrine | EPINEPHRINE | Baxter Healthcare Corporation | ef556382-9d19-4f0e-9dbe-fcecc772a3e2 | 2026-03-30 | Warnings, Adverse reactions | epinephrine EPINEPHRINE |
| epinephrine | EPINEPHRINE | REMEDYREPACK INC. | c66de0d3-3b0f-4e52-a712-60357a107676 | 2026-03-24 | Warnings, Adverse reactions | epinephrine EPINEPHRINE |
| epinephrine | EPINEPHRINE | Amneal Pharmaceuticals of New York LLC | e13f05f1-7d21-49bb-b8d5-24bf9301c3d7 | 2026-03-20 | Warnings, Adverse reactions | epinephrine EPINEPHRINE |
Adverse event summaries are temporarily unavailable. Other product information remains available.